Data as of Apr 17
| +0.19 / +2.76%|
The 6 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 9.50. The median estimate represents a +48.51% increase from the last price of 7.07.
The current consensus among 7 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.